verapamil hydrochloride
- Product NDC
- 53002-1205
- 11-digit product format
- 530021205
- Labeler code
- 53002
- Product ID
- 53002-1205_5d98215f-216d-4831-bac4-65fa9d65a486
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- verapamil hydrochloride
- Dosage form
- TABLET, FILM COATED, EXTENDED RELEASE
- Route
- ORAL
- Labeler
- RPK Pharmaceuticals, Inc.
- Application
- ANDA090700
- Marketing category
- ANDA
- Marketing start
- 2011-08-05
- Marketing end
- 0000-00-00
- Substance
- VERAPAMIL HYDROCHLORIDE
- Active strength
- 180 mg/1
- Pharmacologic classes
- P-Glycoprotein Inhibitors [MoA],Calcium Channel Antagonists [MoA],Calcium Channel Blocker [EPC],Cytochrome P450 3A4 Inhibitors [MoA],Cytochrome P450 3A Inhibitors [MoA]
- NDC exclude flag
- No
- Listing certified through
- 2021-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 53002-1205-0 | verapamil hydrochloride | 100 in 1 BOTTLE | TABLET, FILM COATED, EXTENDED RE | 100 | | 8 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 53002-1205 | VERAPAMIL HYDROCHLORIDE TABLET, FILM COATED, EXTENDED RELEASE [RPK PHARMACEUTICALS, INC.] | 8 | Legacy NDC, 1 package rows | 20230609_b800f810-0a23-4eb0-9ef2-da3979e084a5.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 53002-1205-0 | 53002120500 | 100 TABLET, FILM COATED, EXTENDED RELEASE in 1 BOTTLE (53002-1205-0) | 2018-10-01 | 0000-00-00 | No | No | Current |